Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Dermatology
/ Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Complimentary
Categories:
Activity Type
,
Online Activity
,
Credit Type
,
ANCC
,
CME
,
Dermatology
,
Endocrinology
,
Family Medicine
,
Pediatrics
,
Profession
,
Nurse
,
Nurse Practitioner
,
Physician
,
Physician Assistant
Related products
Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Read more
Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis
Read more
New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Read more
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Read more
Scroll To Top